Hepatitis C, Acute: Clinical Trials

1 trial for Hepatitis C, Acute, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Hepatitis C, Acute: new trials by email Literature Review of Hepatitis C, Acute trials Research Report on Hepatitis C, Acute

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P
Paritaprevir/ritonavir/ombitasvir, Dasabuvir, Ribavirin - Hepatitis C, Acute
Phase 3CompletedKirby Institute832016-06-012022-08-22

Narrower conditions

Hepatitis C (1)

Broader conditions

Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Digestive System Diseases (1)  ·  Flaviviridae Infections (1)  ·  Hepatitis (1)  ·  Hepatitis, Viral, Human (1)  ·  Infections (1)  ·  Liver Diseases (1)  ·  RNA Virus Infections (1)  ·  Virus Diseases (1)

Interventions

Ribavirin (1)  ·  Viekira Pak (1)  ·  dasabuvir (1)  ·  glecaprevir and pibrentasvir (1)  ·  paritaprevir (1)

Sponsors

Kirby Institute (1)

Countries

Australia (1)  ·  New Zealand (1)  ·  United Kingdom (1)

Top investigators

Gail Matthews, MBBS PhD (1)

Results publications

PMID 37771545